Health Economics Outcomes Research

Bayer   •  

Palm Springs, CA

Industry: Business Services

  •  

5 - 7 years

Posted 359 days ago

Your tasks and responsibilities

The primary responsibilities of this role, U.S. Field Health Economics Outcomes Research – West Coast Region, are to: 

 

  • Lead the development & implementation of U.S. Data Generation and Observational Studies (DG&OS) research in the field for the Bayer productportfolio;
  • Responsible for DG&OS research plans with customers to meet their informational needs;
  • Design and conduct studies including outcomes, economics and epidemiology studies;
  • Interact with Managed Care Organizations (MCOs), Center for Medicare & Medicaid Services (CMS) and Key Opinion Leaders (KOLs) to deliver value messages for product pricing and reimbursement and utilization;
  • Develop communication/publication strategies for DG&OS;
  • Proactively share scientific information with brand aligned national/regional key accounts/customers and the key opinion leaders within those organizations as well as local thought leaders in both evidence-based medicine and health economics;
  • Depending on the life cycle/needs of a product, proactively share scientific information with brand aligned national/regional key customers.  For approved products, share high level educational scientific information, and clinical guidelines differentiating product attributes as well as outcomes studies with key decision makers within National and regional accounts;
  • For non-approved products/indications, educate KOLs on ongoing/planned scientific studies, publications, disease state, mechanism of action, burden of illness, prevalence, and other company approved information in the public domain;
  • For all products, develop and maintain high level scientific relationships with key health outcomes thought leaders;
  • Provide field based health outcomes information/education to physicians and other clinicians.  Address unsolicited queries with medical accuracy and fair balance;
  • For U.S. Managed Care, provide proactive communications including formulary presentations, complex medical information/clinical and health economics and outcomes data, and build peer-to-peer relationship with Managed Care Medical/Pharmacy Directors in collaboration account lead;
  • Initiate key field-based health economics and outcomes research studies from conception, through protocol development, to execution, completion and dissemination;
  • Facilitate Bayer sponsored Phase IV studies if appropriate, identifying study sites as needed;
  • Represent DG&OS at US Medical, health economics, and managed care Congresses and Conventions;
  • Monitor and facilitate pre-Congress abstract submissions to the publications review process, attend poster sessions and oral presentations during scientific meetings and provide post-meeting reports summarizing key data from scientific meeting;
  • Actively gather and monitor competitive intelligence;
  • Provide health economics and outcomes research education and project training to Market Access;
  • Review content relating to health economics or observational research for customer facing material developed for Market Access.

 

This position will be responsible for covering Oregon, Washington, California, Nevada, Utah, Arizona, and Colorado.

 

Who you are

Your success will be driven by your demonstration of our LIFE values.  More specifically related to this position, Bayer seeks an incumbent who possesses the following:

 

RequiredQualifications:

 

  • Ph.D. in health economics or related healthcare or economics discipline;
  • At least five (5) years’ progressive experience in health economics and outcomes research in the pharmaceutical industry, including at least two to three (2-3) years’ experience in managing project teams;
  • Self-directed, ability to work alone, entrepreneurial, collaborative;
  • Sound understanding of health economic research principles;
  • Ability to think strategically and make sound health economic and business decisions;
  • Sound understanding of pricing, reimbursement and government agency requirements, as well as the competitive economic dynamics of the pharmaceutical industry.